Marketing-authorisation holder · United States
Neos Theraps
4 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADZENYS ER1.25mg base/ml · Suspension, extended release | Amfetamine | United States | Not marketed | 2017 |
| ADZENYS XR-ODT12.5mg base | 15.7mg base | 18.8mg base | 3.1mg base | 6.3mg base | 9.4mg base · Tablet, orally disintegrating, extended release | Amfetamine | United States | Marketed | 2016 |
| COTEMPLA XR-ODT17.3mg | 25.9mg | 34.6mg | 8.6mg · Tablet, orally disintegrating, extended release | Methylphenidate | United States | Marketed | 2017 |
| HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX8mg maleate/5ml; 10mg bitartrate/5ml · Suspension, extended release | Chlorpheniramine polistirex, Hydrocodone polistirex | United States | Not marketed | 2012 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 4 | 4 | 0 | Companies |